Adagene Inc. (ADR)
General ticker "ADAG" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $69.5M (TTM average)
Adagene Inc. (ADR) follows the US Stock Market performance with the rate: 21.4%.
Estimated limits based on current volatility of 3.3%: low 1.93$, high 2.06$
Factors to consider:
- Total employees count: 198 as of 2020
- Price in estimated range
- Earnings for 12 months up through Q4 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [1.01$, 2.55$]
- 2024-12-30 to 2025-12-30 estimated range: [0.85$, 2.18$]
Short-term ADAG quotes
Long-term ADAG plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $10.18MM | $9.29MM | $18.11MM |
| Operating Expenses | $82.54MM | $93.21MM | $41.83MM |
| Operating Income | $-72.36MM | $-83.92MM | $-23.72MM |
| Non-Operating Income | $0.89MM | $4.41MM | $6.46MM |
| Interest Expense | $0.36MM | $0.69MM | $1.11MM |
| R&D Expense | $68.10MM | $81.34MM | $36.64MM |
| Income(Loss) | $-71.48MM | $-79.51MM | $-17.25MM |
| Taxes | $1.70MM | $0.46MM | $1.69MM |
| Profit(Loss)* | $-73.18MM | $-79.97MM | $-18.95MM |
| Stockholders Equity | $156.56MM | $83.09MM | $70.56MM |
| Assets | $189.51MM | $152.40MM | $115.73MM |
| Operating Cash Flow | $-43.41MM | $-48.61MM | $-28.45MM |
| Capital expenditure | $2.51MM | $0.69MM | $0.09MM |
| Investing Cash Flow | $-2.51MM | $-0.69MM | $-0.08MM |
| Financing Cash Flow | $145.36MM | $17.82MM | $-5.37MM |
| Earnings Per Share** | $-2.29 | $-2.31 | $-0.55 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.